GEN Exclusives

More »

GEN News Highlights

Back to Item »

Lotus Raises $26M in Series A to Progress Recombinant Collagen Type VII Platform

Firm also inks license to USC patent estate and will use new funds to advance therapy for genetic skin diseases.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »